(Q51203256)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23313809%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

title

Tophaceous gout and high level of hyperuricaemia are both associated with increased risk of mortality in patients with gout (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23313809%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23313809%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Lorea Martinez

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23313809%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Loreto Carmona

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23313809%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

author name string

Ana Maria Herrero-Beites

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23313809%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Jose Ignacio Pijoan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23313809%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Eswar Krishnan

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23313809%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

language of work or name

English

0 references

publication date

12 January 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23313809%20AND%20SRC:MED&resulttype=core&format=json

Annals of the Rheumatic Diseases

22 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23313809%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

volume

73

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23313809%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

page(s)

177-182

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23313809%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23313809%20AND%20SRC:MED&resulttype=core&format=json

Gout and the risk of acute myocardial infarction

22 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202421

Risk of myocardial infarction among patients with gout: a nationwide population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202421

Mortality due to coronary heart disease and kidney disease among middle-aged and elderly men and women with gout in the Singapore Chinese Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202421

Hyperuricemia and untreated gout are poor prognostic markers among those with a recent acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202421

Hyperuricemia and the risk for subclinical coronary atherosclerosis--data from a prospective observational cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202421

Inflammation, oxidative stress and lipids: the risk triad for atherosclerosis in gout

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202421

Gout: update on some pathogenic and clinical aspects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202421

Are either or both hyperuricemia and xanthine oxidase directly toxic to the vasculature? A critical appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202421

Influence of the natural history of disease on a previous diagnosis in patients with gout

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202421

Serum uric acid level and risk for peripheral arterial disease: analysis of data from the multiple risk factor intervention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202421

Long-term cardiovascular mortality among middle-aged men with gout

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202421

Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: prospective study and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202421

Uric acid and oxidative stress: relative impact on cardiovascular risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202421

The epidemiology of hyperuricaemia and gout in Taiwan aborigines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202421

Allopurinol and mortality in hyperuricaemic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202421

Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202421

Serum urate levels and gout flares: analysis from managed care data

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202421

Asymptomatic hyperuricemia: impact of ultrasonography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202421

Studies of uric acid pool size and turnover rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202421

Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202421

EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202421

Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202421

High-resolution ultrasonography of the first metatarsal phalangeal joint in gout: a controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202421

Severity of gouty arthritis is associated with Q-wave myocardial infarction: a large-scale, cross-sectional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202421

An audit of the variability of diagnosis and management of gout in the rheumatology setting: the gout evaluation and management study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202421

10.1136/ANNRHEUMDIS-2012-202421

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23313809%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference